India supplies roughly a fifth of the world's generic medicines by volume and the majority of its vaccines. Every one of those doses travels inside a temperature promise — and the promise, not the freight rate, is the product.
The compliance spine: GDP, CDSCO, and the audit trail
Importing markets hold Indian shippers to WHO/EU Good Distribution Practice: qualified and temperature-mapped vehicles and warehouses, calibrated data loggers on every shipment, documented excursion handling with CAPA, and lane risk assessments before the first carton moves. Domestically, CDSCO oversight and the revised Schedule M GMP regime raise the bar at the factory gate. Airports matter too — DEL, BOM, HYD, and BLR operate IATA CEIV Pharma-certified terminals, with Hyderabad's dedicated pharma cargo facility serving the Genome Valley cluster.
Active vs passive cooling: the decision that sets your cost
Passive systems
- Insulated shippers with PCM/gel packs or vacuum panels — 48–120 hours of autonomy
- No power needed; one-way friendly; significantly cheaper
- Right for: CRT generics, short lanes, parcel-size biologics
- Risk: autonomy expires in transit delays — size for the lane's worst case, not its average
Active systems
- Powered, thermostat-controlled ULDs (Envirotainer, CSafe, DoKaSch) with compressor cooling and heating
- Lease per trip roughly $3,000–8,000+ per container
- Right for: high-value biologics, multi-leg routings, extreme ambient profiles
- Bonus: live telemetry on many units — excursion alarms in flight
Designing a zero-excursion lane from India
- 01Map the lane end to end — tarmac time at origin is the classic excursion point; Indian summer apron temperatures demand cool-chain handling windows and CEIV terminals.
- 02Qualify packaging against the lane profile, not the brochure: worst-case ambient, worst-case duration, door-to-door.
- 03Instrument every shipment with calibrated loggers (and live telemetry for high-value loads) — excursion data you see in transit is a save; data you discover at destination is a write-off.
- 04Pre-clear both ends: our in-house brokers file advance entries so product never waits dockside while its autonomy window burns.
- 05Review monthly: excursion rate, on-time performance, and cost per kilo per lane — then re-tender the weak legs.